Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Delayed Canadian Securities Exchange
Other stock markets
 02:54:15 2024-12-12 pm EST 		5-day change 1st Jan Change
0.1700 CAD 0.00% Intraday chart for Entheon Biomedical Corp. +6.25% +70.00%
Dec. 02 Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding CI
Oct. 24 Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer
23-07-31
 CI
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director
23-03-02
 CI
Entheon Biomedical Corp. Appoints Henry Kranzler to the Advisory Board
21-12-01
 CI
Entheon Biomedical Corp. Appoints David Erritzoe to Entheon's Advisory Board
21-08-25
 CI
Entheon Biomedical Appoints Andy Greenshaw to Advisory Board
21-07-28
 CI
Entheon Biomedical Corp. Announces the Appointment of Dinesh Bayana as a Medical Advisor
21-06-30
 CI
Entheon Biomedical Corp. Announces Nancy Maher as Special Advisor of Data Science and Regulatory Affairs
21-03-03
 CI
Entheon Biomedical Corp. Appoints Dr. Brian Jahns to the Role of Chief Business Officer
21-02-16
 CI
Entheon Biomedical Corp. Appoints Scott Keeney as Media Advisor
21-01-11
 CI
MPV Announces Executive Changes
19-10-01
 CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. News Entheon Biomedical Corp.
  5. Insiders